XML 23 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 1,483 $ 1,805
Trade receivables - third party and affiliates 1,289 1,243
Non-trade receivables, net 536 541
Inventories 2,354 2,357
Other assets 283 272
Total current assets 5,945 6,218
Investments in affiliates 1,238 1,220
Property, plant and equipment (net of accumulated depreciation - 2024: $4,243; 2023: $4,080) 5,471 5,584
Operating lease right-of-use assets 396 422
Deferred income taxes 1,618 1,677
Other assets 537 524
Goodwill 6,926 [1] 6,977
Intangible assets, net 3,902 3,975
Total assets 26,033 26,597
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 2,439 1,383
Trade payables - third party and affiliates 1,447 1,510
Other liabilities 1,011 1,154
Income taxes payable 28 25
Total current liabilities 4,925 4,072
Long-term debt, net of unamortized deferred financing costs 11,018 12,301
Deferred income taxes 1,016 999
Uncertain tax positions 298 300
Benefit obligations 444 457
Operating lease liabilities 296 325
Other liabilities 505 591
Commitments and Contingencies
Shareholders' Equity    
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2024 and 2023: 0 issued and outstanding) 0 0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2024: 170,780,600 issued and 109,210,286 outstanding; 2023: 170,476,740 issued and 108,906,426 outstanding) 0 0
Treasury stock, at cost (2024: 61,570,314 shares; 2023: 61,570,314 shares) (5,488) (5,488)
Additional paid-in capital 383 394
Retained earnings 12,973 12,929
Accumulated other comprehensive income (loss), net (797) (744)
Total Celanese Corporation shareholders' equity 7,071 7,091
Noncontrolling interests 460 461
Total equity 7,531 7,552
Total liabilities and equity $ 26,033 $ 26,597
[1] There were no accumulated impairment losses as of March 31, 2024.